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KGF, a multipurpose skin protector
Keratinocyte growth factor (KGF), a member of the fibroblast 
growth factor family, exerts both a mitogenic and a cytopro-
tective effect on epithelial cells in the gastrointestinal tract, 
lung, bladder, and hair follicles. As this factor has been used 
to treat patients who develop oral mucositis in response to 
radiation and chemotherapy, an understanding of the details 
of the cytoprotective effect in each tissue type is advantageous 
for clinical use. Braun and colleagues demonstrated that KGF 
protected hair follicle epithelial cells from apoptosis in the 
presence of cytotoxic stress by reactive oxygen species and 
electrophilic agents. Interestingly, this growth factor also pro-
tected the epithelial cells from UV damage. KGF conferred pro-
tection through binding of the high-affinity receptor FGFR2IIIb, 
activation of multiple signaling pathways, and de novo protein 
synthesis. Since this powerful effect was noted in response to 
chemotherapeutic agents and KGF does not promote tumor 
growth, future studies are warranted to investigate the potential 
for KGF treatment of hair follicles in patients undergoing che-
motherapy for malignancies. (J Cell Sci 119:4841–9, 2006)
Ubiquitin protease prevents tumors
Cylindromatosis (CYLD) is a ubiquitin-carboxyterminal hydro-
lase, which is mutated in patients with familial cylindromato-
sis, characterized by tumors of the hair follicles and the sweat 
glands of the head and neck. In vitro studies suggested that this 
deubiquitinating enzyme downregulates NF-κB activity; how-
ever, the role of this protein in vivo remains obscure. Using 
CYLD-deficient mice, Zhang and colleagues recently showed 
that this protein provides post-translational regulation for both 
the c-Jun N-terminal kinase and NF-κB signaling pathways. 
Activation of these pathways was enhanced only in CYLD-
deficient immune cells after antigen receptor stimulation. In a 
mouse model of colitis-associated cancer, CYLD-deficient mice 
exhibited an increase in intestinal inflammation and a concom-
itant increase in colonic tumors. This finding implicates CYLD 
as a tumor suppressor via its regulatory action on critical signal-
ing pathways. (J Clin Invest 116:3042–9, 2006)
Epidermal barrier depends on Arnt
The aryl hydrocarbon receptor nuclear translocator (Arnt) is 
a transcription factor that dimerizes with multiple partners to 
perform functions in multiple biological pathways. Roles in the 
toxic response to dioxin-like pollutants and in hypoxia impli-
cate Arnt as an important regulator of environmental adapta-
tion; however, the molecular mechanism of these actions is not 
clearly defined. The epidermal barrier provides a biosensor to 
transduce changes in the environment. Geng and colleagues 
demonstrated an epidermal barrier defect in conditional Arnt 
knockout mice. In addition, genetic profiling in the knockout 
epidermis showed upregulation of keratinocyte differentia-
tion genes, indicating that Arnt is not merely a transcriptional 
activator. Understanding the effects of Arnt on the regulation 
of epidermal differentiation complex factors on chromosome 
3, protease inhibitors, and lipid-related enzymes is critical for 
dissecting the coordinated expression of late epidermal differ-
entiation genes. Taken together, these results implicate Arnt in 
physiological adaptation via epidermal homeostasis during the 
perinatal-to-postnatal transition. (J Cell Sci 119:4901–12, 2006)
Alternative splicing of desmoglein 1 
Alternative splicing of pre-messenger RNA permits synthesis of 
vast numbers of proteins from a limited number of genes. This 
mechanism may contribute to autoimmune diseases via the pro-
duction of novel lymphocyte epitopes. Mouquet and colleagues 
described an alternative epidermal transcript of the desmoglein 
1 (DSG1) gene, whose protein is critical for calcium-dependent 
cell–cell adhesion in desmosomal junctions. Dsg1 is the auto-
antigen of pemphigus foliaceus (PF), a blistering skin disease 
involving autoantibody responses. Importantly, a peptide of the 
alternatively transcribed gene induced T-cell proliferation in PF 
patients. Several of these patients carried the major histocom-
patibility complex (MHC) HLA class II alleles (DRβ1*0102 and 
*0101), which have been implicated in genetic susceptibility to 
PF. These MHC alleles also exhibited high affinities for the alter-
native Dsg1 peptide in in vitro binding experiments. From these 
data, the authors speculated that autoreactive T cells activate 
specific B cells and instigate the production of the autoantibod-
ies implicated in PF. (J Immunol 177:6517–26, 2006)
CCN3 mitigates melanocyte 
development
During development, melanocytes migrate to the epidermis 
and attach to the basement membrane upon contact with kera-
tinocytes. Development of melanocytes must be tightly regulat-
ed, as these cells cannot survive in the upper epidermal layers 
and must remain at stable levels with respect to keratinocytes. 
Fukunaga-Kalabis and colleagues recently discovered that the 
matricellular protein CCN3 (nephroblastoma overexpressed) is 
upregulated in melanocytes upon contact with keratinocytes in 
culture. CCN3 serves to decrease the growth of melanocytes 
in order to regulate melanocyte spatial location and number. 
Interestingly, discoidin domain receptor 1 (DDR1), a recep-
tor tyrosine kinase, was upregulated in CCN3-overexpressing 
melanocytes. CCN3 appears to mediate this developmental 
effect via collagen type IV adhesion to the basement membrane 
through interaction with DDR1, although other downstream 
effectors were implicated, as a decrease in DDR1 did not abro-
gate the growth inhibition. Regulation of CCN3, therefore, is 
essential in maintaining correct melanocyte development and 
homeostasis. (J Cell Biol 175:563–9, 2006)
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